医学信息
醫學信息
의학신식
MEDICAL INFORMATION
2014年
24期
358-359
,共2页
依达拉奉%疏血通%缺血性脑卒中
依達拉奉%疏血通%缺血性腦卒中
의체랍봉%소혈통%결혈성뇌졸중
Edaravone%Shuxuetong%Ischemic stroke
目的：总结依达拉奉联合疏血通治疗急性缺血性脑卒中的临床疗效。方法观察60例急性期缺血性脑卒中患者，随机分为对照组30例和治疗组30例，治疗组予依达拉奉和疏血通；对照组予疏血通治疗。结果治疗组总有效率83.3%，明显优于对照组的66.7%(<0.05)。结论依达拉奉联合疏血通治疗急性缺血性脑卒中的疗效显著，对改善患者的临床症状有很好的疗效。
目的：總結依達拉奉聯閤疏血通治療急性缺血性腦卒中的臨床療效。方法觀察60例急性期缺血性腦卒中患者，隨機分為對照組30例和治療組30例，治療組予依達拉奉和疏血通；對照組予疏血通治療。結果治療組總有效率83.3%，明顯優于對照組的66.7%(<0.05)。結論依達拉奉聯閤疏血通治療急性缺血性腦卒中的療效顯著，對改善患者的臨床癥狀有很好的療效。
목적：총결의체랍봉연합소혈통치료급성결혈성뇌졸중적림상료효。방법관찰60례급성기결혈성뇌졸중환자，수궤분위대조조30례화치료조30례，치료조여의체랍봉화소혈통；대조조여소혈통치료。결과치료조총유효솔83.3%，명현우우대조조적66.7%(<0.05)。결론의체랍봉연합소혈통치료급성결혈성뇌졸중적료효현저，대개선환자적림상증상유흔호적료효。
Objective To summarize the clinical ef ect of edaravone combined with Shuxuetong injection in treatment of acute ischemic stroke. Methods 60 patients with acute ischemic stroke patients, were randomly divided into control group of 30 cases and 30 cases in the treatment group, treatment group was treated with edaravone and Shuxuetong injection; control group was treated with Shuxuetong treatment. Results The total effective rate of treatment group was 83.3%, significantly better than the control group 66.7% ( <0.05). Conclusion The therapeutic ef ect of edaravone combined with Shuxuetong injection in treatment of acute ischemic stroke significantly, has a good ef ect on improving clinical symptoms of patients.
